ALU-INSERTION Yb8NBC36 IN THE KCNJ6 GENE IS A RISK FACTOR FOR PARKINSON’S DISEASE
Gilyazova I1,*, Khidiyatova I1, Akhmetova V1, Baitimerov A2, Magzhanov R2, Khusnutdinova E1
*Corresponding Author: Dr. Irina Gilyazova, Department of Human Genomics, Institute of Biochemistry and Genetics, Ufa Science Center, Russian Academy of Sciences, 71 Prospekt Oktyabrya, Ufa 450054, Russia; Tel.: +7(3472)356088; Fax: +7(3472)356100; E-mail: gilyasova_irina@mail.ru
page: 43

INTRODUCTION

Parkinson’s Disease (PD) is a slowly progressive neurode­generative disorder with typical clinical features, such as resting tremor, cogwheel rigidity, bradykinesia, and postural instability. It is due to the relatively selective loss of dopaminergic neurons in the substantia nigra pars compacta, which leads to profound reduction in striatal dopamine (DA). It is the second most frequent neurode­generative disorder after Alzheimer’s Disease, with a prev­alence of 1-2% in people over the age of 50 years. The frequency of PD in the Bashkortostan Republic varies from 3.2 to 117 per 100,000 adults. In the overwhelming majority of PD patients, the disease has been thought to occur sporadically. But there is increasing evidence for a genetic contribution to the disorder [1,2]. Genetic suscepti­bility factors acting together with environmental exposure may lead to the development of this late-onset disease. Thus, molecular-genetic studies that identify causative genes and susceptibility alleles of PD may elucidate the molecular pathways of the development of PD.

      Animal models can play an important role in detecting genetic defects that lead to the disease. One model for PD is the homozygous weaver mouse, a mutant mouse strain, which displays progressive postnatal depletion of dopa­minergic cells in the mesencephalon and age-dependent dopaminergic neuronal loss [3-7]. A homozygous mutation in the H5 pore region of mGIRK2, a putative G-protein inward rectifier K+ channel, is responsible for the weaver mouse [8]. The human homologue of mGIRK2, also known as KCNJ6, KIR3.2, BIR1, KATP2 or KCNJ7, has been mapped to chromosome 21q22 [4,5]. The G-protein-gated inwardly rectifying potassium channels are found in neurons, atrial myocytes and neuroendocrine cells [9], and are characteristically activated by Gi/o-coupled receptors. A possible involvement of this gene in the pathogenesis of PD has been discussed [6,7].

      In recent years, Alu-insertion polymorphisms have been intensively investigated in different populations, and in human genetics have been proposed to contribute to many human diseases. Deininger and Batzer [10] have found 16 examples of diseases caused by the insertion of Alu-elements, suggesting that they may contribute to about 0.1% of all human genetic disorders, including neurofibro­matosis, Apert’s Syndrome, cholinesterase deficiency, hypocalciuric hypercalcemia, breast cancer and hereditary desmoid disease.

      The aim of our study was to determine the association of the Alu-insertion Yb8NBC36 in the human inwardly-rectifying K-channel gene (KCNJ6) with occurrence of idiopathic PD in patients from the Bashkorostan Republic. It is a republic within the Russian Federation that is located in the Volga-Ural region, at the border of Europe and Asia. Bashkortostan is comprised of inhabitants of various ethnic origins; 36.32% of inhabitants are Russians, 29.76% Bashkirs, 24.14% Tatars, and the remaining 9.78% are Chuvashes, Maris, Ukrainians, Udmurts, Belo­russians, etc. (All-Russia Census, 2002).

 




Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006